HIGHLIGHTS
- who: Helena Cristu00f3bal and collaborators from the Department of Cell Death and Proliferation, Institute of Biomedical Research of Barcelona (IIBB-CSIC), Community Heart Failure Program, Department of Cardiology, Bellvitge University Hospital, L`Hospitalet Llobregat, Spain have published the paper: Prognostic Value of Soluble AXL in Serum from Heart Failure Patients with Preserved and Reduced Left Ventricular Ejection Fraction, in the Journal: (JOURNAL)
- what: The specific objectives of this study were to define the value of sAXL as a biomarker in patients with chronic HFpEF patients compared to a similar cohort of HFrEF patients, to compare . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.